Skip to main content

Akebia Therapeutics, Inc 8-K, filed Nov 16, 2026

Akebia Therapeutics, Inc. (AKBA)

8-K 2026-11-16 For: 2026-11-12
View Original
Added on November 16, 2026

About this 8-K

Akebia Therapeutics, Inc filed this 8-K on November 16, 2026, reporting on events of November 12, 2026.

Akebia Therapeutics entered a term loan facility with Symbiotic Capital on November 12, 2026. It funded a $60.0 million tranche, repaid its $55.0 million BlackRock loan in full, and may request up to $80.0 million more, subject to lender discretion. AI summary

Items reported

  • Item 1.01: Entered into a material agreement
  • Item 1.02: Ended a material agreement
  • Item 2.03: New debt or off-balance-sheet obligation
  • Item 3.02: Unregistered sale of equity
  • Item 7.01: Regulation FD disclosure
  • Item 8.01: Other events
  • Item 9.01: Financial statements and exhibits